# Clinical Trial of Deferasirox Combination Treatment With Deferiprone In Thalassaemia Patients

> **NCT02198508** · NA · COMPLETED · sponsor: **China Medical University Hospital** · enrollment: 13 (actual)

## Conditions studied

- Beta-thalassemia Major

## Interventions

- **DRUG:** DFX(Deferasirox)
- **DRUG:** DFP(Deferiprone)

## Key facts

- **NCT ID:** NCT02198508
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-07
- **Final completion:** —
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2014-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02198508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02198508, "Clinical Trial of Deferasirox Combination Treatment With Deferiprone In Thalassaemia Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02198508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*